<!DOCTYPE html>
<html lang="en">
  <head>
    <meta charset="utf-8">
    <title>PorMedTec</title>
    <meta name="viewport" content="width=device-width, initial-scale=1">
    <link rel="icon" href="i/favicon.png" type="image/x-icon">
    <!-- AOS 3.0.0-beta.6 plugin CSS (Animations) -->
    <link rel="stylesheet" href="https://unpkg.com/aos@next/dist/aos.css">
    <!-- Google Fonts -->
    <link href="https://fonts.googleapis.com/css2?family=Inter:wght@100;200;300;400;500;600;700;800;900&family=Inter:wght@100;200;300;400;500;600;700;800;900&subset=latin&display=swap" rel="stylesheet">
    <!-- Startup CSS + Bootstrap CSS (Styles for all blocks) - Remove ".min" if you want to edit a css code -->
    <link href="css/styles.css" rel="stylesheet">
    <!-- Custom Styles -->
    <link href="css/custom.css" rel="stylesheet" type="text/css">
    <!-- jQuery 3.6.0 (uncomment line below if you need jQuery) -->
    <!-- <script src="https://cdnjs.cloudflare.com/ajax/libs/jquery/3.6.0/jquery.min.js"></script> -->
    <link rel="apple-touch-icon" sizes="180x180" href="apple-touch-icon.png">
    <link rel="icon" type="image/png" sizes="32x32" href="favicon-32x32.png">
    <link rel="icon" type="image/png" sizes="16x16" href="favicon-16x16.png">
    <link rel="manifest" href="site.webmanifest">
    <link rel="mask-icon" href="safari-pinned-tab.svg" color="#5bbad5">
    <!-- Global site tag (gtag.js) - Google Analytics -->
    <script async src="https://www.googletagmanager.com/gtag/js?id=G-J40NN60MZB"></script>
    <script>
      window.dataLayer = window.dataLayer || [];

      function gtag() {
        dataLayer.push(arguments);
      }
      gtag('js', new Date());
      gtag('config', 'G-J40NN60MZB');
    </script>
  </head>
  <body>
    <!-- Navigation -->
    <nav class="bg-bg-3 sticky-top py-lg-7 py-2" style="padding-right: 0px; margin-right: 0px;">
      <div class="d-block d-lg-none">
        <div class="container">
          <div class="row align-items-center justify-content-between">
            <div class="text-center col-4 ps-7 pe-2" data-aos="fade-down" data-aos-delay="0">
              <a href="#" class="float-start">
                <img src="i/logo.svg" alt="" class="w-100 float-start" data-aos="fade-down" data-aos-delay="0" srcset="i/logo.svg 2x">
              </a>
            </div>
            <div class="col-4" data-aos="fade-down" data-aos-delay="500"></div>
            <div class="col-4" data-aos="fade-down" data-aos-delay="250">
              <a href="#" class="btn d-lg-none custom-mobile-nav-btn font-body fs-5 btn-width-equal-height bg-bg-3 float-end" data-bs-toggle="offcanvas" data-bs-target="#custom-id-f99iwd8u">
                <svg width="26" height="26" viewBox="0 0 16 16" fill="none" xmlns="http://www.w3.org/2000/svg" class="fill-dark-2">
                  <path d="M2.00016 5.33333H14.0002C14.177 5.33333 14.3465 5.2631 14.4716 5.13807C14.5966 5.01305 14.6668 4.84348 14.6668 4.66667C14.6668 4.48986 14.5966 4.32029 14.4716 4.19526C14.3465 4.07024 14.177 4 14.0002 4H2.00016C1.82335 4 1.65378 4.07024 1.52876 4.19526C1.40373 4.32029 1.3335 4.48986 1.3335 4.66667C1.3335 4.84348 1.40373 5.01305 1.52876 5.13807C1.65378 5.2631 1.82335 5.33333 2.00016 5.33333ZM14.0002 10.6667H2.00016C1.82335 10.6667 1.65378 10.7369 1.52876 10.8619C1.40373 10.987 1.3335 11.1565 1.3335 11.3333C1.3335 11.5101 1.40373 11.6797 1.52876 11.8047C1.65378 11.9298 1.82335 12 2.00016 12H14.0002C14.177 12 14.3465 11.9298 14.4716 11.8047C14.5966 11.6797 14.6668 11.5101 14.6668 11.3333C14.6668 11.1565 14.5966 10.987 14.4716 10.8619C14.3465 10.7369 14.177 10.6667 14.0002 10.6667ZM14.0002 7.33333H2.00016C1.82335 7.33333 1.65378 7.40357 1.52876 7.5286C1.40373 7.65362 1.3335 7.82319 1.3335 8C1.3335 8.17681 1.40373 8.34638 1.52876 8.4714C1.65378 8.59643 1.82335 8.66667 2.00016 8.66667H14.0002C14.177 8.66667 14.3465 8.59643 14.4716 8.4714C14.5966 8.34638 14.6668 8.17681 14.6668 8C14.6668 7.82319 14.5966 7.65362 14.4716 7.5286C14.3465 7.40357 14.177 7.33333 14.0002 7.33333Z"></path>
                </svg>
              </a>
            </div>
          </div>
        </div>
      </div>
      <div class="offcanvas offcanvas-start bg-dark-2" id="custom-id-f99iwd8u" aria-hidden="true">
        <div class="offcanvas-header">
          <a href="#" class="w-50">
            <img src="i/logow.svg" alt="" class="img-fluid w-auto" srcset="i/logow.svg 2x">
          </a>
          <a href="#" class="btn btn-sm btn-width-equal-height" data-bs-dismiss="offcanvas">
            <svg width="24" height="24" viewBox="0 0 16 16" fill="none" xmlns="http://www.w3.org/2000/svg" class="fill-action-8">
              <path d="M8.9398 8L13.1398 3.80667C13.2653 3.68113 13.3359 3.51087 13.3359 3.33333C13.3359 3.1558 13.2653 2.98554 13.1398 2.86C13.0143 2.73447 12.844 2.66394 12.6665 2.66394C12.4889 2.66394 12.3187 2.73447 12.1931 2.86L7.9998 7.06L3.80646 2.86C3.68093 2.73447 3.51066 2.66394 3.33313 2.66394C3.1556 2.66394 2.98533 2.73447 2.8598 2.86C2.73426 2.98554 2.66374 3.1558 2.66374 3.33333C2.66374 3.51087 2.73426 3.68113 2.8598 3.80667L7.0598 8L2.8598 12.1933C2.79731 12.2553 2.74771 12.329 2.71387 12.4103C2.68002 12.4915 2.6626 12.5787 2.6626 12.6667C2.6626 12.7547 2.68002 12.8418 2.71387 12.9231C2.74771 13.0043 2.79731 13.078 2.8598 13.14C2.92177 13.2025 2.99551 13.2521 3.07675 13.2859C3.15798 13.3198 3.24512 13.3372 3.33313 13.3372C3.42114 13.3372 3.50827 13.3198 3.58951 13.2859C3.67075 13.2521 3.74449 13.2025 3.80646 13.14L7.9998 8.94L12.1931 13.14C12.2551 13.2025 12.3288 13.2521 12.4101 13.2859C12.4913 13.3198 12.5785 13.3372 12.6665 13.3372C12.7545 13.3372 12.8416 13.3198 12.9228 13.2859C13.0041 13.2521 13.0778 13.2025 13.1398 13.14C13.2023 13.078 13.2519 13.0043 13.2857 12.9231C13.3196 12.8418 13.337 12.7547 13.337 12.6667C13.337 12.5787 13.3196 12.4915 13.2857 12.4103C13.2519 12.329 13.2023 12.2553 13.1398 12.1933L8.9398 8Z"></path>
            </svg>
          </a>
        </div>
        <div class="offcanvas-body">
          <div>
            <a href="index.html#profile" class="py-2 d-inline-block font-body text-action-8 fw-5 fs-3"> About </a>
          </div>
          <div>
            <a href="index.html#platform" class="py-2 d-inline-block font-body text-action-8 fw-5 fs-3"> Platform </a>
          </div>
          <div>
            <a href="index.html#pipeline" class="py-2 d-inline-block font-body text-action-8 fw-5 fs-3"> Pipelines </a>
          </div>
          <div>
            <a href="index.html#service" class="py-2 d-inline-block font-body text-action-8 fw-5 fs-3"> Service </a>
          </div>
          <div>
            <a href="index.html#contact" class="py-2 d-inline-block font-body text-action-8 fw-5 fs-3"> Contact </a>
          </div>
          <div class="mt-8">
            <a href="https://pormedtec.com" class="btn btn-sm btn-outline-action-8 font-body rounded-1 fs-6 fw-5"> Japanese </a>
          </div>
        </div>
      </div>
      <div class="d-none d-lg-block">
        <div class="container">
          <div class="row justify-content-between align-items-center">
            <div class="col-xl-3 col-2">
              <a data-bs-target="" href="#">
                <img src="i/logo.svg" alt="" class="img-fluid" data-aos="fade-down" data-aos-delay="0" srcset="i/logo.svg 2x">
              </a>
            </div>
            <div class="text-end align-item-center col-xl-9 col-10">
              <a href="#profile" class="text-dark-2 font-heading fw-6 mx-2" data-aos="fade-down" data-aos-delay="150" data-bs-target=""> About </a>
              <a href="#platform" class="text-dark-2 font-heading fw-6 mx-2" data-aos="fade-down" data-aos-delay="250" data-bs-target=""> Technology </a>
              <a href="#pipeline" class="text-dark-2 font-heading fw-6 mx-2" data-aos="fade-down" data-aos-delay="400"> Pipeline </a>
              <a href="#service" class="text-dark-2 font-heading fw-6 mx-2" data-aos="fade-down" data-aos-delay="500" data-bs-target=""> Service </a>
              <a href="#contact" class="text-dark-2 font-heading fw-6 text-start mx-2" data-aos="fade-down" data-aos-delay="650" data-bs-target=""> Contact </a>
              <a href="https://pormedtec.com" class="btn btn-sm btn-outline-dark-2 font-body rounded-1 ms-3 fs-6" data-aos="fade-down" data-aos-delay="750"> Japanese </a>
            </div>
          </div>
        </div>
      </div>
    </nav>
    <!-- Header 2 -->
    <header class="bg-size-cover text-start px-sm-16 px-md-0 px-8 bg-position-top-center py-16 vh-100" data-bg-src-2x="i/i12.jpg" data-bg-src="i/i12.jpg">
      <div class="container text-start text-md-start my-xl-10">
        <h2 class="text-light-1 text-xl-start font-heading text-lg-start text-start text-break mb-6 mb-xl-10 mb-md-6 mt-8 mt-xl-4 display-3 lh-sm text-capitalize" data-aos="fade-down" data-aos-delay="0"> The Future of Transplantation </h2>
        <p class="remove-br text-xl-start text-light-1 font-body opacity-90 fw-5 text-lg-start text-md-start mb-4 mb-md-8 pb-xl-4 mb-xl-8 lh-sm fs-1" data-aos="fade-down" data-aos-delay="250"> Toward the future of organ transplantation and <br>regeneration medicine using bioengineered medical-grade porcine organs. </p>
        <p class="mb-6 remove-br text-xl-start font-body fs-3 mb-md-4 fw-6 text-lg-start mt-xl-12 mt-16 pt-xl-4 text-light-1 opacity-80" data-aos="fade-down" data-aos-delay="250"> Our mission </p>
        <p class="font-body lh-base text-xl-start text-lg-start remove-br text-start text-action-8 opacity-90" data-aos="fade-down" data-aos-delay="250"> Our goal is to provide transplantable organs, tissues, and cells to patients <br>with organ failure or intractable diseases. </p>
        <p class="mb-6 remove-br text-xl-start font-body fs-3 text-light-1 mb-md-4 fw-6 text-lg-start mt-8 mt-xl-8 pt-xl-4 opacity-80" data-aos="fade-down" data-aos-delay="250"> What is a medical-grade pig? </p>
        <p class="font-body lh-base text-xl-start text-lg-start remove-br text-start text-action-8 opacity-90" data-aos="fade-down" data-aos-delay="250"> We generated designated pathogen-free (DPF) pigs with enhanced functions <br>using cutting-edge bioengineering technologies, including somatic cell cloning. </p>
      </div>
    </header>
    <!-- Content -->
    <section class="py-lg-20 bg-bg-3 px-4 py-16">
      <div class="container">
        <div class="row justify-content-lg-between">
          <div class="col-lg-3">
            <h2 class="text-sm-start font-heading mb-xxl-1 text-dark-2 text-capitalize mb-8 mb-lg-8 display-6" data-aos="fade-down" data-aos-delay="0"> About us </h2>
          </div>
          <div class="col-lg-9">
            <p class="mb-xl-6 font-body text-dark-1 mb-4" data-aos="fade-down" data-aos-delay="250"> PorMedTec Co. Ltd. was established in February 2017 based on research outcomes of the Meiji University International Institute for Bio-Resource Research (MUIIBR) led by Professor Hiroshi Nagashima. MUIIBR is a globally leading group in animal bioengineering, including the production of cloned pigs, generation of pig models for human genetic diseases, organ regeneration using blastocyst complementation, and cryopreservation of embryos and organoids. </p>
            <p class="mb-xl-6 font-body text-dark-1 mb-4" data-aos="fade-down" data-aos-delay="250" > In 2021, we established our new mission: to provide transplantable organs, tissues, and cells for the treatment of patients with organ failure or intractable diseases, thereby contributing to global medical care and human health. To achieve this goal in the fastest way, we explored an innovative business using bioengineered medical-grade pigs as hosts to manufacture cost-competitive products with a reliable and stable supply. </p>
          </div>
        </div>
      </div>
    </section>
    <!-- Message -->
    <section class="py-10 bg-action-3 pb-lg-10 pt-lg-20 px-4 pt-16">
      <div class="container">
        <div class="row">
          <div class="col-md-11 col-lg-8 col-xl-7 col-xxl-8">
            <h2 class="mb-6 font-heading display-5 text-action-6" data-aos="fade-down" data-aos-delay="0"> Unmet medical needs to be addressed </h2>
            <p class="text-dark-1 mb-4" data-aos="fade-down" data-aos-delay="150"> Only 2% of patients on the waiting list with end-stage organ failure can undergo transplantation therapy in Japan due to the lack of organ donors. Organ shortage is also a serious issue in the United States; 17 people die every day while waiting for a transplant. </p>
            <p class="mb-8 text-dark-1" data-aos="fade-down" data-aos-delay="150"> Current treatments, such as dialysis, burden patients and their families and generally result in a decreased quality of life (QOL). Furthermore, the medical costs are enormous: in Japan, 2 trillion yen is spent annually on renal dialysis, constituting 4% of the total medical expenditure of the country. </p>
          </div>
        </div>
        <div class="row mb-15">
          <div class="mb-8 col-sm-6 col-md-4 col-lg-3 mb-md-0 mb-sm-8" data-aos="fade-down" data-aos-delay="250">
            <div class="col-12 d-flex align-items-end mb-4">
              <h2 class="font-heading text-dark-1 remove-br display-4 me-1"> 2 </h2>
              <div class="text-dark-1 font-heading text-start fw-bold fs-1"> % </div>
            </div>
            <p class="fs-4 mb-0 fw-6"> Organ transplantation performed / Patients on the waiting list </p>
          </div>
          <div class="mb-8 col-sm-6 col-md-4 col-lg-3 mb-sm-8 mb-md-0" data-aos="fade-down" data-aos-delay="250">
            <div class="col-12 d-flex align-items-end mb-4">
              <h2 class="font-heading text-dark-1 remove-br display-4 me-1"> 17 </h2>
              <div class="text-dark-1 font-heading text-start fw-bold fs-1"> People/Day </div>
            </div>
            <p class="fs-4 mb-0 fw-6"> Number of deaths per day among waiting patients </p>
          </div>
          <div class="mb-sm-0 col-sm-6 col-md-4 col-lg-3 mb-4" data-aos="fade-down" data-aos-delay="250">
            <div class="col-12 d-flex align-items-end mb-4">
              <h2 class="font-heading text-dark-1 remove-br display-4 me-1"> 4 </h2>
              <div class="text-dark-1 font-heading text-start fw-bold fs-1"> % </div>
            </div>
            <p class="fs-4 mb-0 fw-6"> Economic burden of dialysis on the national medical expenditure in Japan </p>
          </div>
        </div>
        <div class="row mb-15 align-items-end">
          <div class="mb-8 mb-sm-0 col-sm-12 col-lg-7" data-aos="fade-down" data-aos-delay="250">
            <div class="col-12 d-flex align-items-end mb-4">
              <h5 class="text-capitalize font-body text-bg-2 me-2 fs-4"> Patients on the waiting list vs. Transplants Performed </h5>
              <h5 class="me-1 text-capitalize font-body text-bg-2 fs-5"> (2020) </h5>
            </div>
            <img src="i/fioew.svg" srcset="i/fioew.svg 2x" alt="" class="img-fluid w-100">
            <p class="mb-0 fw-normal text-light-3 fs-5"> Source: Organdonor.gov　 </p>
          </div>
          <div class="mb-sm-0 col-sm-12 mt-lg-16 mt-12" data-aos="fade-down" data-aos-delay="250">
            <h3 class="font-heading text-action-7"> PorMedTec’s unique core technologies will provide patients with innovative new therapies that are urgently needed. </h3>
          </div>
        </div>
      </div>
    </section>
    <!-- Competencies -->
    <section class="py-10 text-center bg-action-6 pt-lg-20 pb-lg-16 px-4 pt-16">
      <div class="container">
        <div class="row justify-content-center">
          <div class="col-md-9 col-lg-7 col-xl-6 col-xxl-5">
            <h2 class="font-heading text-action-8 mb-12 display-6" data-aos="fade-down" data-aos-delay="0"> Core Competencies </h2>
          </div>
        </div>
        <div class="row justify-content-center">
          <div class="mb-8 mb-lg-0 col-sm-8 col-md-7 col-lg-4 d-flex" data-aos="fade-down" data-aos-delay="0">
            <div class="w-100 p-8 p-md-16 p-lg-8 p-xl-12 border border-1 rounded-2 border-light-2 p-xxl-15">
              <svg width="124" height="124" viewBox="0 0 124 124" fill="none" xmlns="http://www.w3.org/2000/svg" class="fill-action-8 mb-6 fill-action-6 fill-action-5">
                <path d="M41.3332 113.667C38.2332 113.667 36.1665 111.6 36.1665 108.5V46.5C36.1665 43.4 38.2332 41.3333 41.3332 41.3333C44.4332 41.3333 46.4998 43.4 46.4998 46.5V108.5C46.4998 111.6 44.4332 113.667 41.3332 113.667Z"></path>
                <path opacity="0.3" d="M20.6667 77.5C17.5667 77.5 15.5 75.4333 15.5 72.3333V31C15.5 27.9 17.5667 25.8333 20.6667 25.8333C23.7667 25.8333 25.8333 27.9 25.8333 31V72.3333C25.8333 75.4333 23.7667 77.5 20.6667 77.5ZM67.1667 98.1667V15.5C67.1667 12.4 65.1 10.3333 62 10.3333C58.9 10.3333 56.8333 12.4 56.8333 15.5V98.1667C56.8333 101.267 58.9 103.333 62 103.333C65.1 103.333 67.1667 101.267 67.1667 98.1667ZM87.8333 82.6667V25.8333C87.8333 22.7333 85.7667 20.6667 82.6667 20.6667C79.5667 20.6667 77.5 22.7333 77.5 25.8333V82.6667C77.5 85.7667 79.5667 87.8333 82.6667 87.8333C85.7667 87.8333 87.8333 85.7667 87.8333 82.6667ZM108.5 93V51.6667C108.5 48.5667 106.433 46.5 103.333 46.5C100.233 46.5 98.1667 48.5667 98.1667 51.6667V93C98.1667 96.1 100.233 98.1667 103.333 98.1667C106.433 98.1667 108.5 96.1 108.5 93Z"></path>
              </svg>
              <h5 class="font-heading text-action-8 lh-base fs-4 text-wrap"> Leading bioengineering technologies for genetic engineering and cloning of pigs </h5>
            </div>
          </div>
          <div class="mb-8 mb-lg-0 col-sm-8 col-md-7 col-lg-4 d-flex" data-aos="fade-down" data-aos-delay="0">
            <div class="w-100 p-8 p-md-16 p-lg-8 p-xl-12 border border-1 rounded-2 border-light-2 p-xxl-15">
              <svg width="124" height="124" viewBox="0 0 124 124" fill="none" xmlns="http://www.w3.org/2000/svg" class="fill-action-8 fill-action-6 fill-action-5 mb-6">
                <path opacity="0.3" d="M44.9503 31C41.8503 29.45 38.2335 27.9001 35.1335 26.3501C40.3002 20.6667 45.9836 15.5 52.1836 11.3667C55.2836 10.85 58.9003 10.3333 62.0003 10.3333C65.6169 10.3333 68.7169 10.85 71.8169 11.3667C62.0003 16.5333 52.7003 23.25 44.9503 31ZM62.0003 43.4C71.8169 34.1 83.7003 27.3834 96.6169 23.7667C93.5169 20.6667 89.9003 18.6 86.2836 16.5333C74.4003 21.1833 63.0336 27.9001 54.2503 36.6834C56.8336 38.7501 59.4169 40.8166 62.0003 43.4Z"></path>
                <path d="M36.1666 103.333C36.1666 104.367 36.1666 105.4 36.1666 106.433C32.0333 103.85 28.4165 101.267 25.3165 98.1667C23.7665 93 20.6666 88.8667 16.5333 85.7667C14.4666 81.6333 12.9165 77.5 11.8832 72.85C25.8332 75.95 36.1666 88.35 36.1666 103.333ZM54.7666 51.1497C44.95 41.8497 33.0665 35.6498 19.6332 32.5498C17.5665 35.6498 15.4999 38.7497 14.4665 42.3664C27.8999 44.4331 39.7833 50.6331 49.0833 59.9333C50.6333 56.3167 52.6999 53.7328 54.7666 51.1497ZM11.3666 52.1833C10.85 55.2833 10.3333 58.9 10.3333 62C10.3333 62 10.3333 62 10.3333 62.5167C22.2166 64.0667 33.0666 70.7833 39.2666 80.6C40.3 76.4667 41.8499 72.8495 43.3999 69.2328C35.6499 59.9328 24.2833 53.7333 11.3666 52.1833ZM56.8333 103.333C56.8333 72.3333 79.5666 46.4998 109.533 41.8498C107.983 38.2331 106.433 35.1331 104.367 32.0331C71.2999 38.7497 46.4999 67.6828 46.4999 102.816C46.4999 105.399 46.5 108.5 47.0166 111.083C50.6333 112.117 54.2499 112.633 57.8666 113.149C57.3499 110.049 56.8333 106.95 56.8333 103.333ZM98.6833 98.1667C100.233 93 103.333 88.8667 107.467 85.7667C109.533 81.6333 111.083 77.5 112.117 72.85C98.1666 75.95 87.3166 88.35 87.3166 103.333C87.3166 104.367 87.3166 105.4 87.3166 106.433C91.9666 104.367 95.5833 101.267 98.6833 98.1667ZM77.4999 103.333C77.4999 82.15 93.5166 65.1 113.667 62.5167C113.667 62.5167 113.667 62.5167 113.667 62C113.667 58.3833 113.15 55.2833 112.633 52.1833C86.7999 55.2833 67.1666 76.9833 67.1666 103.333C67.1666 106.95 67.6833 110.049 68.1999 113.149C71.8166 112.633 74.9166 112.117 78.5333 111.083C78.0166 108.5 77.4999 105.917 77.4999 103.333Z"></path>
              </svg>
              <h5 class="font-heading text-action-8 lh-base fs-4 text-wrap"> High-quality manufacturing of transplantable organs/tissues/cells using medical-grade designated pathogen-free (DPF) pigs produced by an original low-cost U-iR system </h5>
            </div>
          </div>
          <div class="mb-8 mb-lg-0 col-sm-8 col-md-7 col-lg-4 d-flex" data-aos="fade-down" data-aos-delay="0">
            <div class="w-100 p-8 p-md-16 p-lg-8 p-xl-12 border border-1 rounded-2 border-light-2 p-xxl-15">
              <svg width="124" height="124" viewBox="0 0 124 124" fill="none" xmlns="http://www.w3.org/2000/svg" class="fill-action-8 mb-6 fill-action-6 fill-action-5">
                <path d="M62.2296 92.7127V62.746L88.0629 77.7294C96.3296 82.3794 98.9134 93.2294 94.2634 101.496C89.6134 109.763 78.7634 112.346 70.4967 107.696C65.3301 104.596 62.2296 98.9127 62.2296 92.7127ZM36.3965 77.7294L62.2296 62.746L36.3965 47.763C28.1298 43.113 17.7964 45.6963 12.6298 53.9627C7.97978 62.2294 10.5632 72.5627 18.8298 77.7294C24.5132 80.8294 31.2298 80.8294 36.3965 77.7294ZM62.2296 32.7796V62.746L88.0629 47.763C96.3296 43.113 98.9134 32.2629 94.2634 23.9963C89.6134 15.7296 78.7634 13.1463 70.4967 17.7963C65.3301 20.8963 62.2296 26.5796 62.2296 32.7796Z"></path>
                <path opacity="0.3" d="M36.3957 47.763C31.229 44.663 27.6123 38.9796 27.6123 32.7796C27.6123 23.4796 35.3624 15.7296 44.6624 15.7296C53.9622 15.7296 61.7122 23.4796 61.7122 32.7796V62.7461L36.3957 47.763ZM88.0622 77.7294C93.2289 80.8294 99.9455 80.8294 105.112 77.7294C113.379 73.0794 115.962 62.2294 111.312 53.9627C106.662 45.6963 95.8122 43.113 87.5455 47.763L61.7122 62.7461L88.0622 77.7294ZM36.3957 77.7294C31.229 80.8294 27.6123 86.5128 27.6123 92.7128C27.6123 102.013 35.3624 109.763 44.6624 109.763C53.9622 109.763 61.7122 102.013 61.7122 92.7128V62.7461L36.3957 77.7294Z"></path>
              </svg>
              <h5 class="font-heading text-action-8 lh-base fs-4"> Production of humanized organs using the DPF pigs and human pluripotent stem cells </h5>
            </div>
          </div>
        </div>
      </div>
    </section>
    <!-- Core Business -->
    <section class="bg-action-6 pt-lg-0 px-4 pb-16 pb-lg-20 pt-0">
      <div class="container">
        <div class="row">
          <div class="col-xxl-6 mb-lg-0 mb-4 mx-lg-0 col-md-11 col-lg-5 col-xl-5 col-12 col-sm-12">
            <h5 class="font-heading text-action-8 mt-0 fw-6 opacity-80 mb-7" data-aos="fade-down" data-aos-delay="250"> Core Business </h5>
            <h3 class="my-6 font-heading text-action-8 fw-6 lh-sm" data-aos="fade-down" data-aos-delay="250" > We are developing human-compatible organs, tissues, and cells using our platform technologies by genetically engineering pigs. Our unique production system for medical-grade DPF pigs facilitates domestic and global business development in a cost-competitive manner. </h3>
          </div>
          <div class="d-none d-md-block col-md-1 col-lg-1"></div>
          <div class="col-md-12 mb-8 mb-lg-0 col-sm-12 col-12 col-xxl-5 col-lg-6">
            <div class="mb-8" data-aos="fade-down" data-aos-delay="0">
              <div class="mb-8">
                <h5 class="text-light-1 font-heading fw-6 opacity-80"> Mission Statement </h5>
              </div>
              <div>
                <h3 class="text-light-1 font-body lh-sm fw-6"> Our mission is to fulfill the increasing demand for transplantable organs, improve the quality of life for patients and their families, and reduce the economic burden associated with transplantation medicine. </h3>
              </div>
            </div>
          </div>
        </div>
      </div>
    </section>
    <!-- Platform 1 -->
    <section class="py-lg-20 bg-action-3 px-4 py-16 pt-16 pt-lg-20 pb-lg-20 pb-4" id="platform">
      <div class="container">
        <div class="row align-items-md-center justify-content-between">
          <div class="mb-8 mb-md-0 col-lg-6 col-xl-5 col-xxl-5 col-12 text-start">
            <h5 class="text-center text-md-start font-heading text-action-6 mb-1" data-aos="fade-down" data-aos-delay="250"> Platform Technology </h5>
            <h5 class="mb-6 text-md-start font-heading text-action-6 display-1 fw-light text-center" data-aos="fade-down" data-aos-delay="400"> #1 </h5>
            <h1 class="mb-6 text-center text-md-start font-heading text-dark-2 lh-sm text-capitalize display-6" data-aos="fade-down" data-aos-delay="500"> Generation of genetically engineered pigs </h1>
            <p class="fs-4 mb-0 text-dark-2 text-center fw-5 text-md-start text-lg-start text-xl-start font-body" data-aos="fade-down" data-aos-delay="650"> PorMedTec's genetic bioengineering platform includes genetic modifications of porcine somatic and embryonic cells. We also make full use of our sophisticated artificial reproductive technologies, including somatic cell cloning, in vitro oocyte maturation and fertilization, ICSI-mediated gene transfer, embryo cryopreservation, blastocyst complementation, and fetal surgery, to create and propagate pigs with improved traits for medical use. </p>
          </div>
          <div class="col-xl-6 col-12 col-lg-5 mt-8 mt-lg-0">
            <img src="i/frame-45.svg" srcset="i/frame-45.svg 2x" alt="" class="img-fluid w-100" data-aos="fade-down" data-aos-delay="750">
          </div>
        </div>
      </div>
    </section>
    <!-- Platform 2 -->
    <section class="bg-action-3 pt-lg-0 px-4 pt-8 pb-lg-20 pb-12" id="dpf">
      <div class="container">
        <div class="justify-content-lg-between border-bottom border-action-6 border-1 opacity-40 row g-0 mb-16"></div>
        <div class="justify-content-lg-between align-items-center row g-0">
          <div class="col-lg-5 col-12 text-center text-md-start">
            <h5 class="mb-4 font-heading text-action-6 mb-lg-1" data-aos="fade-down" data-aos-delay="0"> Platform Technology </h5>
            <h2 class="font-heading display-1 fw-light text-action-6 mb-4 mb-lg-6" data-aos="fade-down" data-aos-delay="0"> #2 </h2>
            <h1 class="mb-4 mb-lg-0 font-heading text-dark-2 lh-sm text-capitalize display-6" data-aos="fade-down" data-aos-delay="0"> Medical-grade designated pathogen-free (DPF) pigs </h1>
          </div>
          <div class="col-lg-6 col-12 mt-8 mt-lg-0">
            <div class="border border-1 rounded-2 p-12 col-lg-12 border-action-6">
              <p class="mb-0 font-body fw-6" data-aos="fade-down" data-aos-delay="250"> We developed a unique U-iR (Uterectomy isolated rearing) system to produce DPF pigs that satisfies the hygienic standards for xenotransplantation. </p>
            </div>
            <div class="border border-action-6 border-1 rounded-2 p-12 col-lg-12 mt-4">
              <p class="mb-0 font-body fw-6" data-aos="fade-down" data-aos-delay="250"> In 2021, we started a five-year project on the development of a DPF pig production/ application facility with the support of the Japan Agency for Medical Research and Development. </p>
            </div>
          </div>
        </div>
      </div>
    </section>
    <!-- Publications -->
    <section class="py-lg-20 bg-dark-2 px-4 py-16">
      <div class="container">
        <div class="row justify-content-center text-center text-md-center text-lg-center text-xl-center">
          <div class="mb-4 col-lg-4 col-12">
            <h2 class="font-heading text-action-8 mb-1 text-lg-start text-xl-start display-6" data-aos="fade-down" data-aos-delay="0"> Publications </h2>
          </div>
          <div class="mb-6 col-lg-8 col-12">
            <p class="text-light-2 mb-2 text-lg-start fs-4" data-aos="fade-down" data-aos-delay="150"> PorMedTec was established as a spin-off venture at the Meiji University International Institute for Bio-Resource Research (MUIIBR). The comprehensive partnership agreement between PorMedTec and Meiji University allows us to utilize all the research outcomes of the MUIIBR. </p>
            <p class="text-light-2 mb-2 text-lg-start fs-4" data-aos="fade-down" data-aos-delay="150"> Please refer to the following URL to access the publications of <a href="https://muiibr.com/paperresult/&#10;" target="_blank"> MUIIBR </a>
            </p>
          </div>
        </div>
        <div class="row">
          <div class="col-md-6 col-lg-4 mb-6" data-aos="fade-down" data-aos-delay="250">
            <div class="border rounded-2 h-100 p-6 border-bg-2">
              <h4 class="font-heading text-action-8 mb-4 fw-6 text-capitalize"> Diabetes model pig </h4>
              <p class="text-light-2 font-body mb-4 fs-5"> Umeyama K, Watanabe M, Saito H, Kurome M, Tohi S, Matsunari H, Miki H, Nagashima H: Dominant t-negative mutant hepatocyte nuclear factor 1alpha induces diabetes in transgenic-cloned pigs. Transgenic Research, 18(5): 697-706, 2009. </p>
              <p class="text-light-2 font-body mb-0 fs-5"> Umeyama K, Nakajima M, Yokoo T, Nagaya M, Nagashima H: Diabetic phenotype of transgenic pigs introduced by dominant-negative mutant hepatocyte nuclear factor 1α. Journal of Diabetes and its Complications, 31(5):796-803, 2017. </p>
            </div>
          </div>
          <div class="col-md-6 col-lg-4 mb-6" data-aos="fade-down" data-aos-delay="250">
            <div class="border rounded-2 h-100 p-6 border-bg-2">
              <h4 class="font-heading text-action-8 mb-4 fw-6 text-capitalize"> Immunodeficient pig </h4>
              <p class="text-light-2 font-body mb-0 fs-5"> Watanabe M, Nakano K, Matsunari H, Matsuda T, Maehara M, Kanai T, Kobayashi M, Matsumura Y, Sakai R, Kuramoto M, Hayashida G, Asano Y, Takayanagi S, Arai Y, Umeyama K, Nagaya M, Hanazono Y, Nagashima H: Generation of interleukin-2 receptor gamma gene knockout pigs from somatic cells genetically modified by zinc finger nuclease-encoding mRNA. PLOS ONE 8:e76478, 2013. </p>
            </div>
          </div>
          <div class="col-md-6 col-lg-4 mb-6" data-aos="fade-down" data-aos-delay="250">
            <div class="border rounded-2 h-100 p-6 border-bg-2">
              <h4 class="font-heading text-action-8 mb-4 fw-6 text-capitalize"> Pancreatogenesis-disabled pig </h4>
              <p class="text-light-2 font-body mb-0 fs-5"> Matsunari H, Nagashima H, Watanabe M, Umeyama K, Nakano K, Nagaya M, Kobayashi T, Yamaguchi T, Sumazaki R, Herzenberg L.A., Nakauchi H. Blastocyst complementation generates exogenic pancreas in vivo in apancreatic cloned pigs. Proc Natl Acad Sci USA, 110:4557-4562, 2013. </p>
            </div>
          </div>
          <div class="col-md-6 col-lg-4 mb-6" data-aos="fade-down" data-aos-delay="250">
            <div class="border rounded-2 h-100 p-6 border-bg-2">
              <h4 class="font-heading text-action-8 mb-4 fw-6 text-capitalize"> Renal agenesis pig </h4>
              <p class="text-light-2 font-body mb-0 fs-5"> Matsunari H, Watanabe M, Hasegawa K, Uchikura A, Nakano K, Umeyama K, Masaki H, Hamanaka S, Yamaguchi T, Nagaya M, Nishinakamura R, Nakauchi H, Nagashima H: Compensation of disabled organogeneses in genetically modified pig fetuses by blastocyst complementation. Stem Cell Reports:14:21-33, 2020. </p>
            </div>
          </div>
          <div class="col-md-6 col-lg-4 mb-6" data-aos="fade-down" data-aos-delay="250">
            <div class="border rounded-2 h-100 p-6 border-bg-2">
              <h4 class="font-heading text-action-8 mb-4 fw-6 text-capitalize"> Hepatogenesis-disabled pig </h4>
              <p class="text-light-2 font-body mb-0 fs-5"> Matsunari H, Watanabe M, Hasegawa K, Uchikura A, Nakano K, Umeyama K, Masaki H, Hamanaka S, Yamaguchi T, Nagaya M, Nishinakamura R, Nakauchi H, Nagashima H: Compensation of disabled organogeneses in genetically modified pig fetuses by blastocyst complementation. Stem Cell Reports:14:21-33, 2020. </p>
            </div>
          </div>
          <div class="col-md-6 col-lg-4 mb-6" data-aos="fade-down" data-aos-delay="250">
            <div class="border rounded-2 h-100 p-6 border-bg-2">
              <h4 class="font-heading text-action-8 mb-4 fw-6"> Pigs Lacking Pancreatic β-cells </h4>
              <p class="text-light-2 font-body mb-0 fs-5"> Nagaya M, Hasegawa K, Watanabe M, Nakano K, Okamoto K, Yamada T, Uchikura A, Osafune K, Yokota H, Nagaoka T, Matsunari H, Umeyama K, Kobayashi E, Nakauchi H, Nagashima H: Genetically engineered pigs manifesting pancreatic agenesis with severe diabetes. BMJ Open Diabetes Research &amp; Care, 8:e001792, 2020. </p>
            </div>
          </div>
          <div class="col-md-6 col-lg-4 mb-6" data-aos="fade-down" data-aos-delay="250">
            <div class="border rounded-2 h-100 p-6 border-bg-2">
              <h4 class="font-heading text-action-8 mb-4 fw-6 text-capitalize"> Marfan syndrome model pig </h4>
              <p class="text-light-2 font-body mb-0 fs-5"> Umeyama K, Watanabe K, Watanabe M, Horiuchi K, Nakano K, Kitashiro M, Matsunari H, Kimura T, Arima Y, Sampetrean O, Nagaya M, Saito M, Saya H, Kosaki K, Nagashima H, Matsumoto M: Generation of heterozygous fibrillin-1 mutant cloned pigs from genome-edited foetal fibroblasts. Scientific Reports, 6:24413, 2016. </p>
            </div>
          </div>
          <div class="col-md-6 col-lg-4 mb-6" data-aos="fade-down" data-aos-delay="250">
            <div class="border rounded-2 h-100 p-6 border-bg-2">
              <h4 class="font-heading text-action-8 mb-4 fw-6 text-capitalize"> Dilated cardiomyopathy model pig </h4>
              <p class="text-light-2 font-body mb-0 fs-5"> Matsunari H, Honda M, Watanabe M, Fukushima S, Suzuki K, Miyagawa S, Nakano K, Umeyama K, Uchikura A, Okamoto K, Nagaya M, Toyooka T, Sawa Y, Nagashima H: Pigs with δ-sarcoglycan deficiency exhibit traits of genetic cardiomyopathy. Laboratory Investigation, 100:887-899, 2020. </p>
            </div>
          </div>
          <div class="col-md-6 col-lg-4 mb-6" data-aos="fade-down" data-aos-delay="250">
            <div class="border rounded-2 h-100 p-6 border-bg-2">
              <h4 class="font-heading text-action-8 mb-4 fw-6 text-capitalize"> Compensation of lethal traits by blastocyst complementation </h4>
              <p class="text-light-2 font-body mb-0 fs-5"> Matsunari H, Watanabe M, Nakano K, Enosawa S, Umeyama K, Uchikura A, Yashima S, Fukuda T, Klymiuk N, Kurome M, Kessler B, Wuensch A, Zakhartchenko V, Wolf E, Hanazono Y, Nagaya M, Umezawa A, Nakauchi H, Nagashima H: Modeling lethal X-linked genetic disorders in pigs with ensured fertility. Proc of Natl Acad Sci USA, 115:708-713, 2018. </p>
            </div>
          </div>
        </div>
      </div>
    </section>
    <!-- Pipeline 2 -->
    <section class="bg-action-3 py-10 py-lg-20 px-4" id="pipeline">
      <div class="container">
        <div class="row align-items-md-center justify-content-between">
          <div class="mb-md-0 col-md-7 col-lg-6 col-xxl-6 text-center text-lg-start text-md-start col-xl-6">
            <h5 class="text-center text-md-start font-heading mb-4 text-action-6 text-capitalize" data-aos="fade-down" data-aos-delay="250"> R&amp;D pipelines </h5>
            <div class="my-4 border-bottom border-action-2 border-1 opacity-60"></div>
            <h5 class="text-center text-md-start font-heading mb-12 mt-8 text-action-6 display-5" data-aos="fade-down" data-aos-delay="250"> Xenotransplantation </h5>
            <p class="fs-2 text-center text-md-start mb-0" data-aos="fade-down" data-aos-delay="500"></p>
            <p class="text-action-7 text-lg-start fs-4" data-aos="fade-down" data-aos-delay="250"> The first successful human heart transplantation from a genetically engineered pig occurred on January 7, 2022. This will encourage the clinical application of xenotransplantation for various organs. Kidney xenotransplantation is expected to serve as a cure for numerous patients waiting for kidney transplantation. We are developing DPF pigs with multiple genetic modifications that allow for kidney xenotransplantation. </p>
            <a href="https://www.bbc.com/japanese/59005374" class="btn btn-action-5 text-light-1 my-4 font-body fw-6 px-6 text-md-start text-center text-lg-start text-xl-start btn-lg fs-5" target="_blank" data-aos="fade-down" data-aos-delay="250"> BBC News </a>
          </div>
          <div class="col-xl-5 me-lg-12 col-sm-12 col-md-5">
            <img src="i/figure7.svg" srcset="i/figure7.svg 2x" alt="" class="img-fluid w-100" data-aos="fade-down" data-aos-delay="0">
          </div>
        </div>
      </div>
    </section>
    <!-- Service -->
    <section class="py-lg-20 bg-dark-3 px-4 py-16" id="service">
      <div class="container">
        <div class="row align-items-center justify-content-between">
          <div class="col-lg-5 col-xl-5 mb-8 mb-lg-0 col-12">
            <h5 class="text-light-1 font-heading opacity-80 mb-4 text-capitalize" data-aos="fade-down" data-aos-delay="0"> Technical consulting service </h5>
            <h3 class="text-light-1 font-heading text-capitalize display-5" data-aos="fade-down" data-aos-delay="0"> Cryopreservation technology </h3>
          </div>
          <div class="col-xl-6 col-xxl-6 col-lg-6 col-12">
            <p class="fs-4 text-light-1 fw-6 mb-0" data-aos="fade-down" data-aos-delay="150"> Based on our extensive knowledge on and experience in embryo vitrification, we have developed a unique vitrification technique applicable for the cryopreservation of a variety of subjects, including fetal anlagens, pancreatic islets, organoids, and artificial tissues such as cell sheets. We can provide an optimized cryopreservation protocol for the specific materials of interest. </p>
          </div>
        </div>
        <div class="row justify-content-between align-item-center mb-4 mt-10">
          <div class="col-xl-12 col-lg-12"></div>
        </div>
        <div class="row">
          <div class="col-md-6 col-lg-4 mb-6" data-aos="fade-down" data-aos-delay="250">
            <div class="border rounded-2 h-100 p-6 border-light-2">
              <h4 class="text-light-1 font-heading fw-6 mb-4"> Pancreatic Islets </h4>
              <p class="text-light-1 opacity-80 font-body mb-0 fs-5"> Nagaya M, Matsunari H, Kanai T, Maehara M, Nakano K, Umeki I, Katsumata Y, Kasai Y, Sakai R, Kobayashi M, Honda K, Abe N, Watanabe M, Umeyama K, Nagashima H: An effective new cryopreservation procedure for pancreatic islets using hollow fiber vitrification. Hormone and Metabolic Research, 48(8):540-549, 2016. </p>
            </div>
          </div>
          <div class="col-md-6 col-lg-4 mb-6" data-aos="fade-down" data-aos-delay="250">
            <div class="border rounded-2 h-100 p-6 border-light-2">
              <h4 class="text-light-1 font-heading fw-6 mb-4"> Pig Embryonic Kidneys </h4>
              <p class="text-light-1 opacity-80 font-body mb-0 fs-5"> Matsumoto K, Yokoo T, Matsunari H, Iwai S, Yokote S, Teratani T, Gheisari Y, Tsuji O, Okano H, Utsunomiya Y, Hosoya T, Okano H.J, Nagashima H, Kobayashi E. Xenotransplanted embryonic kidney provides a niche for endogenous mesenchymal stem cell differentiation into erythropoietin-producing tissue. Stem Cells, 30:1228-35, 2012. </p>
            </div>
          </div>
          <div class="col-md-6 col-lg-4 mb-6" data-aos="fade-down" data-aos-delay="250">
            <div class="border rounded-2 h-100 p-6 border-light-2">
              <h4 class="text-light-1 font-heading fw-6 mb-4"> Cell Sheets </h4>
              <p class="text-light-1 opacity-80 font-body mb-0 fs-5"> Maehara M, Sato M, Watanabe M, Matsunari H, Kokubo M, Kanai T, Sato M, Matsumura K, Hyon SH, Yokoyama M, Mochida J, Nagashima H: Development of a novel vitrification method for chondrocyte sheets. BMC Biotechnology, 13:58, 2013. </p>
            </div>
          </div>
        </div>
      </div>
    </section>
    <!-- Service 1 -->
    <section class="py-lg-20 bg-bg-3 px-4 py-16" id="order">
      <div class="container">
        <div class="row justify-content-between align-items-center">
          <div class="col-lg-10 col-xl-12 mb-9">
            <h5 class="font-heading mb-4 text-dark-3 text-capitalize" data-aos="fade-down" data-aos-delay="0"> Technical consulting service </h5>
            <h2 class="mb-0 font-heading text-dark-2 opacity-80 text-capitalize display-5" data-aos="fade-down" data-aos-delay="0"> Made-to-order production of genetically engineered pigs </h2>
          </div>
          <div class="col-md-9 col-xxl-12 col-xl-12 col-lg-12">
            <p class="fs-4 fw-6 mb-8 text-dark-2 opacity-80" data-aos="fade-down" data-aos-delay="150"> Genetically engineered pigs have been utilized for several purposes, including organ regeneration research (ref 1-3) and validation of a new drug/therapy using model pigs (ref 4). We provide a service that creates genetically engineered and cloned pigs to meet the specific requirements of our clients. </p>
          </div>
        </div>
        <div class="row">
          <div class="col-md-6 mb-6 col-lg-3" data-aos="fade-down" data-aos-delay="250">
            <div class="border rounded-2 h-100 p-6 border-light-2">
              <h4 class="fw-6 text-bg-2 mb-4"> 1 </h4>
              <p class="font-body text-dark-3 fs-5 mb-0"> T. Rashid, T. Kobayashi, H. Nakauchi: Revisiting the flight of Icarus: making human organs from PSCs with large animal chimeras </p>
            </div>
          </div>
          <div class="col-md-6 mb-6 col-lg-3" data-aos="fade-down" data-aos-delay="250">
            <div class="border rounded-2 h-100 p-6 border-light-2">
              <h4 class="fw-6 text-bg-2 mb-4"> 2 </h4>
              <p class="font-body text-dark-3 fs-5 mb-sm-0"> Cell Stem Cell, 15 (2014), pp. 406-409. Matsunari H, Nagashima H, Watanabe M, Umeyama K, Nakano K, Nagaya M, Kobayashi T, Yamaguchi T, Sumazaki R, Herzenberg L.A., Nakauchi H. Blastocyst complementation generates exogenic pancreas in vivo in apancreatic cloned pigs. Proc Natl Acad SciUSA, 110:4557-62. 2013. </p>
            </div>
          </div>
          <div class="col-md-6 mb-6 col-lg-3" data-aos="fade-down" data-aos-delay="250">
            <div class="border rounded-2 h-100 p-6 border-light-2">
              <h4 class="fw-6 text-bg-2 mb-4"> 3 </h4>
              <p class="font-body text-dark-3 fs-5 mb-0"> Yokote S, Matsunari H, Iwai S, Yamanaka S, Uchikura A, Fujimoto E, Matsumoto K, Nagashima H, Kobayashi E, Yokoo T: Urine excretion strategy for stem cell-generated embryonic kidneys. Proc Natl Acad Sci USA, 112: 12980-12985, 2015. </p>
            </div>
          </div>
          <div class="col-md-6 mb-6 col-lg-3" data-aos="fade-down" data-aos-delay="250">
            <div class="border rounded-2 h-100 p-6 border-light-2">
              <h4 class="fw-6 text-bg-2 mb-4"> 4 </h4>
              <p class="font-body text-dark-3 fs-5 mb-0"> McGonigle P, Ruggeri B: Animal models of human disease: Challenges in enabling translation. Biochemical Pharmacology, 87: 162-171, 2014. </p>
            </div>
          </div>
        </div>
      </div>
    </section>
    <!-- Profile -->
    <section class="py-lg-20 bg-action-6 px-4 py-16" id="profile">
      <div class="container">
        <div class="row justify-content-lg-between">
          <div class="col-lg-3">
            <h2 class="mb-4 text-light-1 font-heading mb-xxl-1 mb-lg-1 display-6" data-aos="fade-down" data-aos-delay="0"> Corporate <br>Profile </h2>
          </div>
          <div class="col-lg-9">
            <div class="border-action-8 border-top opacity-60 mb-4"></div>
            <div class="row">
              <div class="col-md-3 col-12 mb-2 mb-md-0">
                <div class="text-start py-xxl-1 font-body fw-bold text-action-8 opacity-80"> Address </div>
              </div>
              <div class="col-md-9 col-12">
                <div class="py-xxl-1 text-start text-action-8 font-body" > Meiji University Center of Collaborative Innovation and Incubation, T201 <br> 2-3227 Mita, Tama, Kawasaki 214-0034, Japan </div>
              </div>
            </div>
            <div class="border-action-8 border-top opacity-60 my-4"></div>
            <div class="row">
              <div class="col-md-3 col-12 mb-md-0 mb-1">
                <div class="text-start font-body fw-bold text-action-8 opacity-80 my-1"> Company Background </div>
              </div>
              <div class="col-md-9 col-12">
                <div class="text-start text-action-8 font-body my-1" > PorMedTec was founded in February 2017 with the aim of practical implementation of the research outcomes of the Meiji University International Institute for Bio-Resource Research (MUIIBR). </div>
              </div>
            </div>
            <div class="border-action-8 border-top opacity-60 my-4"></div>
            <div class="row">
              <div class="col-md-3 col-12 mb-1 mb-md-0">
                <div class="text-start font-body fw-bold text-action-8 opacity-80 my-1"> Business Description </div>
              </div>
              <div class="col-md-9 col-12">
                <div class="text-start text-action-8 font-body my-1" > Production and sales of: </div>
                <li class="text-start text-action-8 font-body my-1" > Pancreatic islets for xenotransplantation using genetically engineered pigs </li>
                <li class="text-start text-action-8 font-body my-1" > Humanized organs for transplantation using genetically engineered pigs </li>
                <li class="text-start text-action-8 font-body my-1" > Genetically engineered pig organs for xenotransplantation </li>
                <div class="text-start text-action-8 font-body my-1" > Made-to-order production of genetically engineered pigs </div>
                <div class="text-start text-action-8 font-body my-1" > Technical consulting service for the cryopreservation of biomaterials </div>
              </div>
            </div>
            <div class="border-action-8 border-top opacity-60 my-4"></div>
            <div class="row">
              <div class="col-md-3 col-12 mb-1 mb-md-0">
                <div class="text-start font-body fw-bold text-action-8 opacity-80 my-1"> Shareholders </div>
              </div>
              <div class="col-md-9 col-12">
                <div class="text-start text-action-8 font-body my-1" > Eight Roads Ventures &amp; F-Prime Capital (Global VC backed by Fidelity) </div>
                <div class="text-start text-action-8 font-body my-1" > Management Team </div>
              </div>
            </div>
            <div class="border-action-8 border-top opacity-60 my-4"></div>
            <div class="row">
              <div class="col-md-3 col-12 mb-1 mb-md-0">
                <div class="text-start font-body fw-bold text-action-8 opacity-80 my-1"> Employees </div>
              </div>
              <div class="col-md-9 col-12">
                <div class="text-start text-action-8 font-body my-1" > As of December 2021, ProMedTec currently employs 10 board directors. </div>
              </div>
            </div>
          </div>
        </div>
      </div>
    </section>
    <!-- Team -->
    <section class="py-lg-20 bg-bg-3 py-16 px-4" id="team">
      <div class="container">
        <div class="row">
          <div class="col-md-10 col-lg-8 col-xl-7 col-xxl-6">
            <h2 class="font-heading text-bg-2 mb-4 display-6" data-aos="fade-down" data-aos-delay="0"> Management Team </h2>
          </div>
        </div>
        <div class="row">
          <div class="mb-10 col-12" data-aos="fade-down" data-aos-delay="250">
            <div class="border-bottom border-bottom-dark-2 opacity-30"></div>
          </div>
          <div class="mb-8 col-md-6 mb-xxl-6 col-sm-12 mb-md-6" data-aos="fade-down" data-aos-delay="500">
            <h3 class="font-heading mb-2"> Hiroshi Nagashima, Ph.D. </h3>
            <h5 class="mb-4 font-heading text-action-6"> Founder, Co-CEO, Chief Scientist </h5>
            <p class="font-body text-dark-1 mb-3"> Professor, Laboratory of Medical Bioengineering, Department of Life Sciences, School of Agriculture, Meiji University <br> Director, Meiji University International Institute for Bio-Resource Research </p>
            <p class="font-body text-dark-1 mb-3"> Prof. Hiroshi Nagashima was awarded a Ph.D. from the University of Tokyo in 1984. He started his career working on the embryology of large domestic animals, mainly pigs and cattle, at the Research Center of Nisshin Flour Milling Co., Ltd., Japan. In 1991 he moved to Australia to work as a visiting research fellow at the Department of Obstetrics and Gynecology, Medical School, University of Adelaide, Australia. After this he accepted a position as a senior research scientist at BresaGen Ltd., Australia, where he engaged in a xenotransplantation project. He returned to Japan in 1997, working for two years at the Division of Organ Transplantation, Biomedical Research Center, Osaka University Medical School, before becoming an associate professor at Meiji University in 1999. His current research focus includes the production of genetically modified pigs as potential organ donors for xenotransplantation, in vivo organ regeneration using genetically engineered pigs, creation of disease models using genome editing and somatic cell cloning technology, and cryopreservation of embryos and artificial tissues. </p>
          </div>
          <div class="mb-8 col-md-6 mb-xxl-6 col-sm-12 mb-md-6" data-aos="fade-down" data-aos-delay="500">
            <h3 class="font-heading mb-2"> Genjiro Miwa, MBA </h3>
            <h5 class="mb-4 font-heading text-action-6"> Founder, Co-CEO, Board Director </h5>
            <p class="font-body text-dark-1 mb-3"> Founder &amp; Chairman of Megakaryon Corporation, a producer of iPS platelets  <br> Co-founder and CEO of iCELL, a regenerative medicine patent broker  <br> Co-founder &amp; director of Ardito Asset Management Co., Ltd., an investment firm </p>
            <p class="font-body text-dark-1 mb-3"> After working at Bain &amp; Company, he co-founded BioSurface Technology (currently part of Sanofi) which developed cultured skin substitutes. </p>
            <p class="font-body text-dark-1 mb-3"> Graduated from the University of Tokyo Faculty of Economics <br> Graduated from Harvard Business School (MBA with Distinction) </p>
            <p class="font-body text-dark-1 mb-3"> Council Member of the World Economic Forum (The Davos Agenda) </p>
          </div>
          <div class="mb-8 col-md-6 mb-xxl-6 col-sm-12 mb-md-6" data-aos="fade-down" data-aos-delay="500">
            <h3 class="font-heading mb-2"> Kazu Umeda, M.S. </h3>
            <h5 class="mb-4 font-heading text-action-6"> Board Director </h5>
            <p class="font-body text-dark-1 mb-3"> Co-founder and Represent Director, SIIF Impact Capital Inc., a JV with SIIF, the leading ecosystem builder of impact investing in Japan.
</p>
            <p class="font-body text-dark-1 mb-3"> Prior Experience : <br> M3 Inc. (TYO: 2413)  <br> Venture Investment Partner,Business development group <br> Co-founder & Representative Director, M3i Inc.</p>
            <p class="font-body text-dark-1 mb-3"> INCJ Inc.(Japanese Government Fund) <br> Vice President </p>
            <p class="font-body text-dark-1 mb-3"> Japan Asia Investment Co., Ltd. (TYO: 8518)  <br> Head of CEO’s office, HeadQuarter, Tokyo Japan <br> President, JAIC Asia Holdings Pte Ltd, Singapore <br> President, PT JAIC Indonesia, Jakarta <br> President, JAIC Thailand Co., Ltd, Bangkok <br> Investment Manager, JAIC America, Inc., Palo Alto, California, USA </p>
            <p class="font-body text-dark-1 mb-3"> Membership in professional committee : <br> Evaluation committee member of Ministry of Education, Culture, Sports, Science and Technology <br> Evaluation committee member of Japan Agency for Medical Research and Development (AMED)
 </p>
            <p class="font-body text-dark-1 mb-3"> M.S., Life Sciences, Tokyo University of Pharmacy and Life Sciences, Tokyo, Japan  <br> B.S., Life Sciences, Tokyo University of Pharmacy and Life Sciences, Tokyo, Japan </p>
          </div>
          <div class="mb-8 col-md-6 mb-xxl-6 col-sm-12 mb-md-6" data-aos="fade-down" data-aos-delay="500">
            <h3 class="font-heading mb-2"> Shin-ichiro Komoto </h3>
            <h5 class="mb-4 font-heading text-action-6"> Board Director </h5>
            <p class="font-body text-dark-1 mb-3"> Investment &amp; Development Manager for the healthcare sector at Eight Roads, a Japanese VC that manages funds from Fidelity, a major US financial firm. </p>
            <p class="font-body text-dark-1 mb-3"> At Mitsui &amp; Co., Ltd., where he worked for 18 years, he helped to start new businesses in the IT and healthcare sector and worked on M&amp;A and business management. He lived and worked abroad in the US, Singapore, and Vietnam for nine years. </p>
            <p class="font-body text-dark-1 mb-4"> Tokyo Metropolitan University (Electric Engineering) <br> INSEAD (Executive Educational Program) </p>
          </div>
          <div class="mb-8 col-md-6 mb-xxl-6 col-sm-12 mb-md-6" data-aos="fade-down" data-aos-delay="500">
            <h3 class="font-heading mb-2"> Hirotada Nagai, M.S. </h3>
            <h5 class="mb-4 font-heading text-action-6"> Board Director </h5>
            <p class="font-body text-dark-1 mb-3"> Director, Kyoya Corporation (chemical industry pharmaceutical trading company) </p>
            <p class="font-body text-dark-1 mb-3"> Held various positions within the Ministry of Health, Labour and Welfare, such as the Compliance and Narcotics Division (GMP Advisor) of the Pharmaceutical and Food Safety Bureau, as well as positions in the Research and Development Division (Technical Head Deputy Director) of the Health Policy Bureau. </p>
            <p class="font-body text-dark-1 mb-3"> Experience gained through secondment to the Office of Medical Devices I of the Pharmaceuticals and Medical Devices Agency (PMDA), and the Health and Medical Team in the Strategic Investment Group of the Innovation Network Corporation of Japan (INCJ). </p>
            <p class="font-body text-dark-1 mb-3"> Earned Master of Pharmacy from the Gifu Pharmaceutical University Graduate School of Pharmacy. </p>
          </div>
          <div class="mb-8 col-md-6 mb-xxl-6 col-sm-12 mb-md-6" data-aos="fade-down" data-aos-delay="500">
            <h3 class="font-heading mb-2"> Iichiro Amano </h3>
            <h5 class="mb-4 font-heading text-action-6"> Board Director </h5>
            <p class="font-body text-dark-1 mb-3"> After joining Daiwa Securities, he was engaged in equity sales trading in the Institutional Sales Department. After retiring from Daiwa Securities, he worked as a fund manager and CTO of a investment company, and later worked in corporate management and venture support. </p>
            <p class="font-body text-dark-1 mb-3"> Graduated from Waseda University, School of Commerce. </p>
          </div>
          <div class="mb-8 col-md-6 mb-xxl-6 col-sm-12 mb-md-6" data-aos="fade-down" data-aos-delay="500">
            <h3 class="font-heading mb-2"> Masahiko Hirata </h3>
            <h5 class="mb-4 font-heading text-action-6"> Statutory Auditor </h5>
            <p class="font-body text-dark-1 mb-3"> Examiner at Bank Examination Department, Senior Examiner at Financial System and Bank Examination Department, and Kumamoto Branch Manager of the Bank of Japan; Executive Director at Deposit Insurance Corporation of Japan; Senior Director at Sumitomo Mitsui Trust Bank, Limited; Advisor at Mitsui Life Insurance Company, Limited.</p>
            <p class="font-body text-dark-1 mb-3"> Senior Advisor, YAMADA Consulting Group Co.Ltd. (to present), Senior Advisor, Grant Thornton Taiyo LLC (to present) </p>
            <p class="font-body text-dark-1 mb-3"> Graduated from Waseda University </p>
          </div>
          <div class="mb-8 col-md-6 mb-xxl-6 col-sm-12 mb-md-6" data-aos="fade-down" data-aos-delay="500">
            <h3 class="font-heading mb-2"> Hidetaka Hara, M.D., Ph.D. </h3>
            <h5 class="mb-4 font-heading text-action-6"> Scientific Advisor </h5>
            <p class="font-body text-dark-1 mb-4"> Dr. Hara is currently a Professor at the College of Veterinary Medicine, Yunnan Agricultural University, Kunming, Yunnan, China, where he is working in the xenotransplantation program. He is a fully-trained surgeon, including transplantation surgery, and has a Ph.D. in transplant immunology. Dr. Hara worked in the field of xenotransplantation research with Dr. Cooper for more than 17 years, initially at the University of Pittsburgh. He has extensive experience working with large animal models (e.g., pigs and nonhuman primates). He has participated in pig-to-baboon or monkey heart, liver, kidney, islet, and corneal transplantation, as well as in various pig allotransplantation models. In addition, he has extensive experience with immune assays including immune monitoring of the recipient after xenotransplantation and in vitro assays. He has contributed to illuminating how genetic modifications in pigs can protect their organs from human immune responses.
 </p>
            <div class="position-relative">
              <p class="font-body text-dark-1 mb-1 position-absolute">
                1995
              </p>
              <p class="font-body text-dark-1 mb-2 ps-14">
                Graduated from Kawasaki Medical School, Okayama, Japan (M.D.)
              </p>
            </div>
            <div class="position-relative">
              <p class="font-body text-dark-1 mb-1 position-absolute">
                1996
              </p>
              <p class="font-body text-dark-1 mb-2 ps-14">
                Matsuyama Red Cross Hospital (Surgery), Ehime, Japan
              </p>
            </div>
            <div class="position-relative">
              <p class="font-body text-dark-1 mb-1 position-absolute">
                1998
              </p>
              <p class="font-body text-dark-1 mb-2 ps-14">
                National Hiroshima Hospital (Surgery), Hiroshima, Japan
              </p>
            </div>
            <div class="position-relative">
              <p class="font-body text-dark-1 mb-1 position-absolute">
                2004
              </p>
              <p class="font-body text-dark-1 mb-2 ps-14">
                Graduated from Graduate School of Medical Sciences, Hiroshima University, Hiroshima, Japan (Ph.D.)
              </p>
            </div>
            <div class="position-relative">
              <p class="font-body text-dark-1 mb-1 position-absolute">
                2004
              </p>
              <p class="font-body text-dark-1 mb-2 ps-14">
                Postdoctoral research fellow at the Thomas E. Starzl Transplantation Institute, University of Pittsburgh, Pennsylvania, USA
              </p>
            </div>
            <div class="position-relative">
              <p class="font-body text-dark-1 mb-1 position-absolute">
                2007
              </p>
              <p class="font-body text-dark-1 mb-2 ps-14">
                Research Instructor of Surgery at the Thomas E. Starzl Transplantation Institute, University of Pittsburgh, Pennsylvania, USA
              </p>
            </div>
            <div class="position-relative">
              <p class="font-body text-dark-1 mb-1 position-absolute">
                2011
              </p>
              <p class="font-body text-dark-1 mb-2 ps-14">
                Research Assistant Professor of Surgery at the Thomas E. Starzl Transplantation Institute, University of Pittsburgh, Pennsylvania, USA
              </p>
            </div>
            <div class="position-relative">
              <p class="font-body text-dark-1 mb-1 position-absolute">
                2016
              </p>
              <p class="font-body text-dark-1 mb-2 ps-14">
                Assistant Professor of Surgery at the University of Alabama at Birmingham, Alabama, USA 
              </p>
            </div>
            <div class="position-relative">
              <p class="font-body text-dark-1 mb-1 position-absolute">
                2017
              </p>
              <p class="font-body text-dark-1 mb-2 ps-14">
                Associate Professor of Surgery at the University of Alabama at Birmingham, Alabama, USA
              </p>
            </div>
            <div class="position-relative">
              <p class="font-body text-dark-1 mb-1 position-absolute">
                2022
              </p>
              <p class="font-body text-dark-1 mb-2 ps-14">
                Associate Professor at the College of Veterinary Medicine, Yunnan Agricultural University, Yunnan, China
              </p>
            </div>
            <div class="position-relative">
              <p class="font-body text-dark-1 mb-1 position-absolute">
                2022
              </p>
              <p class="font-body text-dark-1 mb-2 ps-14">
                Professor at the College of Veterinary Medicine, Yunnan Agricultural University, Yunnan, China
              </p>
            </div>
          </div>
        </div>
      </div>
    </section>
    <!-- Contact -->
    <section class="py-lg-20 bg-bg-1 py-16 px-4" id="contact">
      <div class="container">
        <div class="row justify-content-between mb-8">
          <div class="col-md-6 col-lg-5 mb-12 mb-md-0 col-sm-12">
            <h2 class="font-heading mb-12 text-action-8 display-6" data-aos="fade-down" data-aos-delay="0"> Contact </h2>
            <p class="text-light-2 font-body mb-12 fs-4" data-aos="fade-down" data-aos-delay="150"> For further details on our services or products, please make an inquiry via the contact form. </p>
            <div class="position-relative" data-aos="fade-down" data-aos-delay="500">
              <svg width="25" height="24" viewBox="0 0 25 24" fill="none" xmlns="http://www.w3.org/2000/svg" class="fill-action-1 position-absolute top-0 start-0">
                <path fill-rule="evenodd" clip-rule="evenodd" d="M24.2255 0.919479C24.3114 0.989882 24.3805 1.07848 24.428 1.17887C24.4755 1.27925 24.5001 1.38893 24.5 1.49998V21C24.4999 21.1733 24.4398 21.3412 24.3298 21.4752C24.2199 21.6092 24.067 21.701 23.897 21.735L16.397 23.235C16.3 23.2543 16.2 23.2543 16.103 23.235L8.75 21.765L1.397 23.235C1.28823 23.2567 1.176 23.2541 1.06838 23.2272C0.960764 23.2003 0.860444 23.15 0.774649 23.0797C0.688854 23.0093 0.61972 22.9209 0.572228 22.8207C0.524735 22.7204 0.500067 22.6109 0.5 22.5V2.99998C0.500105 2.82666 0.560234 2.65873 0.670165 2.52473C0.780096 2.39074 0.933042 2.29895 1.103 2.26498L8.603 0.764979C8.70004 0.745583 8.79996 0.745583 8.897 0.764979L16.25 2.23498L23.603 0.764979C23.7117 0.743103 23.824 0.745613 23.9316 0.772329C24.0392 0.799045 24.1396 0.849301 24.2255 0.919479ZM15.5 3.61498L9.5 2.41498V20.385L15.5 21.585V3.61498ZM17 21.585L23 20.385V2.41498L17 3.61498V21.585ZM8 20.385V2.41498L2 3.61498V21.585L8 20.385Z"></path>
              </svg>
              <p class="ps-10 mb-0 fs-4 remove-br font-body text-action-8"> Meiji University Center of Collaborative Innovation and Incubation T201, 2-3227 Mita, Tama, Kawasaki 214-0034, Japan </p>
            </div>
          </div>
          <div class="col-md-5 col-xl-4 col-sm-12" data-aos="fade-down" data-aos-delay="650">
            <a href="https://b21bt46kd5b.typeform.com/to/ODYhDTgL" class="btn btn-action-1 btn-lg text-action-8 w-100 fs-3" data-bs-target="" target="_blank"> Contact Form </a>
          </div>
        </div>
      </div>
    </section>
    <!-- Footer -->
    <footer class="bg-dark-2 pb-xxl-8 pb-xl-8 pb-lg-10 pt-sm-12 px-4 pt-12 pt-lg-10 pb-4 pt-xl-8 pt-xxl-8">
      <div class="container mt-xxl-8">
        <div class="row mb-12">
          <div class="mb-8 col-md-12 col-xxl-4 col-xl-3">
            <a href="#">
              <img src="i/logow.svg" alt="" class="img-fluid" data-aos="fade-down" data-aos-delay="0" srcset="i/logow.svg 2x">
            </a>
          </div>
          <div class="mb-sm-8 col-sm-6 mb-4 col-md-6 mb-lg-0 mb-md-4 col-xl-2 col-lg-3" data-aos="fade-down" data-aos-delay="150">
            <h5 class="mb-4 font-heading text-light-2 fw-6"> About Us </h5>
            <a href="#profile" class="me-2 me-sm-0 d-sm-block text-light-1 font-body fs-5 mb-2"> Profile </a>
            <a href="#team" class="me-2 me-sm-0 d-sm-block text-light-1 font-body fs-5 mb-2"> Management Team </a>
          </div>
          <div class="mb-sm-8 col-sm-6 mb-4 col-md-6 mb-md-4 mb-lg-0 col-xl-2 col-lg-3" data-aos="fade-down" data-aos-delay="250">
            <h5 class="mb-4 font-heading text-light-2 fw-6"> Pipelines </h5>
            <a href="#xeno" class="me-2 me-sm-0 d-sm-block text-light-1 font-body fs-5 mb-2"> Islet Xenotransplantation </a>
            <a href="#kidney" class="me-2 me-sm-0 d-sm-block text-light-1 font-body fs-5 mb-2"> Transplantation Therapy With Humanized Kidneys </a>
          </div>
          <div class="mb-sm-8 mb-sm-0 col-sm-6 mb-4 col-md-6 mb-md-4 mb-lg-0 col-xl-2 col-lg-3" data-aos="fade-down" data-aos-delay="400">
            <h5 class="mb-4 font-heading text-light-2 fw-6"> Platforms </h5>
            <a href="#platform" class="me-2 me-sm-0 d-sm-block text-light-1 font-body fs-5 mb-2" data-bs-target=""> Genetically Engineered Pigs </a>
            <a href="#dpf" class="me-2 me-sm-0 d-sm-block text-light-1 font-body fs-5 mb-2"> Medical-Grade DPF Pigs </a>
            <a href="#organ" class="me-2 me-sm-0 d-sm-block text-light-1 font-body fs-5 mb-2"> Development Of Humanized Organs </a>
          </div>
          <div class="col-sm-6 col-md-6 mb-4 mb-sm-8 mb-md-4 mb-lg-0 col-lg-3 col-xxl-2 col-xl-3" data-aos="fade-down" data-aos-delay="500">
            <h5 class="mb-4 font-heading text-light-2 fw-6"> Technical Consulting </h5>
            <a href="#service" class="me-2 me-sm-0 d-sm-block text-light-1 font-body fs-5 mb-2"> Cryopreservation Technology </a>
            <a href="#order" class="me-2 me-sm-0 d-sm-block text-light-1 font-body fs-5 mb-2"> Made-To-Order Production Of Genetically Engineered Pigs </a>
          </div>
        </div>
        <div class="border-top border-action-8 pb-xxl-4 opacity-20 mb-lg-4 mb-xxl-0"></div>
        <div class="border-action-8 opacity-40 row">
          <div class="lh-lg col-6 d-none d-md-block my-4 my-lg-0">
            <p class="fs-6 font-body text-action-8 my-0" data-aos="fade-down" data-aos-delay="650"> Copyright © PorMedTec Co., Ltd. All Rights Reserved. </p>
          </div>
          <div class="text-end col-12 my-4 my-lg-0 col-md-6" data-aos="fade-down" data-aos-delay="750">
            <a href="https://pormedtec.com/en/terms.html" class="font-body fs-6 lh-lg text-light-1 opacity-100 fw-6 me-4 text-center" data-bs-target=""> Terms &amp; Conditions </a>
            <a href="https://pormedtec.com/en/privacy.html" class="font-body lh-lg ms-xxl-4 fs-6 opacity-100 text-action-8 fw-6" data-bs-target=""> Privacy Policy </a>
          </div>
        </div>
      </div>
    </footer>
    <!-- Bootstrap JS -->
    <script src="https://cdn.jsdelivr.net/npm/bootstrap@5.1.2/dist/js/bootstrap.bundle.min.js"></script>
    <!-- AOS 3.0.0-beta.6 plugin JS (Animations) -->
    <script src="https://unpkg.com/aos@next/dist/aos.js"></script>
    <!-- Startup JS (Custom js for all blocks) - Remove ".min" if you want to edit a JS code -->
    <script src="js/scripts.min.js"></script>
  </body>
</html>